Skip to Main Content

Paper Details

Clinico-Genomic Profiling of Conventional and Dedifferentiated Chondrosarcomas Reveals TP53 Mutation to Be Associated with Worse Outcomes.
Clin Cancer Res
0
2023
Chondrosarcomas, Dedifferentiated Chondrosarcomas, IDH, IDH mutations, IDH1, IDH2, Isocitrate, Isocitrate dehydrogenase 1, TP53, TP53 Mutation, TP53 WT, TP53 WT chondrosarcomas, TP53 mutant, TP53 mutations, chondrosarcoma, chondrosarcomas, dedifferentiated chondrosarcomas, grades 1-3 conventional chondrosarcoma, patients, primary bone tumor
Author NameAffiliation
Alexander J LazarThe University of Texas MD Anderson Cancer Center
Alexander J LazarThe University of Texas MD Anderson Cancer Center
Kenna R Mills ShawInstitute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
Kenna R Mills ShawInstitute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center
  • 1 - 4

Datasets

Release 1.2